Amgen's first quarter 2012 revenue increased 9 percent to $4.0 billion
- Details
- Category: Amgen

Strong sales performance in pharmaceuticals and Alcon
- Details
- Category: Novartis

Novo Nordisk and Oxford University team up to develop novel treatments
- Details
- Category: Novo Nordisk

AstraZeneca to acquire Ardea Biosciences for $1 billion
- Details
- Category: AstraZeneca

Novartis updates US label on Gilenya® following discussions with the FDA
- Details
- Category: Novartis

GSK confirms offer to acquire Human Genome Sciences for US$13.00 per share in cash
- Details
- Category: GlaxoSmithKline

GSK provides update on corporate responsibility commitments in 2011 report
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- Abbott's investigational treatment for advanced Parkinson's disease demonstrates positive results
- Roche on track for full-year targets - good sales growth in first quarter
- Takeda to Acquire URL Pharma
- UCB marks World Parkinson's Disease Day with new Parkinson's Well-Being Map™
- Amgen to acquire privately held KAI Pharmaceuticals
- Open-source drug research consortium draws a major new champion
- Roche sends second letter to Illumina shareholders